TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

10.70$ -10.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GOSS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0%
3.6% 2.1%
100.0% 97.9%
120.7% 359.2%
31.5% 77.6%
152.2% 434.7%
-52.2% -336.8%
10.0% 22.7%
-48.5% -351.7%
0.8% -0.2%
-49.3% -351.5%
-34.8% -326.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?